Dyslipidemia and oxidative stress in patients of psoriasis

Biomedical Research

Volumn 22, Issue 2, 2011, Pages 221-224

  Gupta, Madhur ^a   Chari, Suresh ^a   Borkar, Milind ^a   Chandankhede, Manju ^a  

^a NKP SIMS ^*  (India)

Author keywords

Antioxidant enzymes; Lipid profile; Oxidative stress; Psoriasis

Indexed keywords

GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; XANTHINE OXIDASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DYSLIPIDEMIA; ENZYME BLOOD LEVEL; HUMAN; LIPID COMPOSITION; LIPID PEROXIDATION; OXIDATIVE STRESS; PSORIASIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 80051484434     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative Stress and Psoriasis. Antioxid Redox Signal. 2002; 4 (4):665-73.
2. Davidson. Psoriasis. In: Principles and Practice of Medicine. 18 ed. 2002. p. 900.
3. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dyslipidemia and oxida-tive stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001; 303(1-2): 33-39.
4. Ghosh A, Mukhopadhyay S, Kar M. Role of free reactive iron in psoriasis. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2009; 74: 277-278.
5. Baz K, Burak MY, Cimen, Kokturk A. Oxidant/aanti-oxidant status in patients with psoriasis. Yonsei Medical Journal 2003; 44: 987-990.
6. Gyulai R. The immunology of psoriasis: from basic research to the bedside. Orv Hetil. 2006; 147 (46): 2213-2220.
7. Seishima M, Seishima M, Mori S, Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 1994; 130: 738-742.
8. Pietrzak A, Lecewicz-Torun B. Activity of serum lipase and the diversity of serum lipid profile in psoriasis. Med Sci Monit 2002; 8: CR9-CR13.
9. Niemann AL, Shin DB, Wang X, Margolis DJ, Trosxel AB, Gelfand JM. Prevalance of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006: 55: 829-835.
10. Bajaj DR, Mahesar SM, Devrajani BR, Iqbal MP. Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. J Pak Med Assoc 2009 59 (8): 512-515.
11. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichental M. Increased prevalence of the metabolic syndrome in patients with moderate and severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
12. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgilli AR et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis. Results from an Italian case control study. J Invest Dermatol 2005; 125: 61-67.
13. Pietrzak A, Lecewicz- Torun B, Kadziela-Wypyska G. Changes in the digestive system in patients suffering from psoriasis. Ann Univ Mariae Cruie Sklodowska [Med] 1998; 53: 187-194.
14. Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J. Dermatological Sciences. 2001; 27: 27-30.
15. Rocha Pereira P., Silva I Rebelo A S., Figneredo A, Quintanilhas A, Teixeira F. Erythrocyte damage in mild and severe psoriasis. British J. of Dermatol. 2004; 150: 232-244.
16. Relhan V, Gupta S., Dayal S, Pandde R., Lal H. Blood thiol and Malondialdehyde level in psoriasis. The J. of Dermatol. 2002; 29: 399-403.
17. Yildrium M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. J Eur Acad Dermatol Venerol 2003; 17: 34-36.
18. Akhyani M, Ehsani AH, Robati RM, Robati AM. The lipid profile in psoriasis: a controlled study. JEADV 2007; 21: 1330-1332.
19. Stiller MJ, Pak GH, Kenny C et al. Elevation of fasting lipids in patients treated with low-dose cyclosporine for severe plaque type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease. J Am Acad Dermatol 1992; 27: 434-438.
20. Maccarrone M, Catani MV, Iraci S, Melino G, Agro AF. A survey of reactive oxygen species and their role in dermatology. J Eur Acad Dermatol Venerol 1997; 8: 185-202.
21. Popov I, Lewing G. A deficient function of the antioxi-dative system of the organism as an aetiopathogenetic factor in psoriasis. Med Hypothesis 1991, 35; 229-36.
22. Julie B Sedgwick, Paul R Bergstresser and Eric R Hurd. Increased Superoxide Generation by Normal Granulo-cytes Incubated In Sera from Patients with Psoriasis. Journal of Investigative Dermatology 1981 76, 158-163; 1523-1747.
23. Pujari VM, Suryakar AN, Ireddy S. Oxidants and anti-oxidant status in psoriasis patients. Biomedical Res 2010; 21(2): 221-223.
24. Vanizor Kural V, Orem A, Cimsit G, Yandi YE, Cala-poglu M. Evaluation of the atherogenic tendency of lip-ids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003; 328: 71-82.
25. Drewa G, Krzyzynska-Malinowska E, Wozniak A, Protas-Drozd F, Mila-Kierzenkowska C, Rozwodowska M et al Activity of superoxide dismutase and catalase and the level of lipid peroxidation product reactive with TBA in patients with psoriasis. Med Sci Monit 2002; 8: BR338-BR343.
26. Kobayashi T, M. Matsumoto, H. Iizuka, K. Suzuki, N. Taniguchi. Superoxide dismutase in psoriasis, squa-mous cell carcinoma and basal cell epithelioma: an im-munohistochemical study. British Journal of Dermatology 1991; 124 (6): 555-559.
27. Utas S, Kose K, Yazici C, Akdas A, Kelestimur F. Anti-oxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem 2002; 35: 241-246.
28. Kokcam I, Naziroglu M. Antioxidants and lipid peroxi-dation in the blood of patients with psoriasis. Clinica Chimica Acta 1999; 289: 23-33.
29. Combs GF, Combs SB. The nutritional biochemistry of selenium. Ann Rev Nutr 1984; 4: 257-280.
30. Fuchs J, Hiflejt M, Rothfuss L, Wilson D, Carcamo G, Packer L. Impairment of enzymic and nonenzymic anti-oxidants in skin by UVB irridation. J Invest Dermatol 1989; 93: 769-773.
31. Michaelsson G, Berne B, Carlmark B, Strand A. Selenium in whole blood and plasma is decreased in patients with moderate to severe psoriasis. Acta Derm Venereol. 1989; 69 (1): 29-34.
32. Fairris GM, Perkins PJ, Llyod B, Hinks L, Clayton BE. The effect of atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm Venerol 1989; 69: 359-362.